Invention Grant
- Patent Title: Naphthalenesulfonamide compound, preparation method, and application
-
Application No.: US17626505Application Date: 2020-04-13
-
Publication No.: US11773057B2Publication Date: 2023-10-03
- Inventor: Qidong You , Zhengyu Jiang , Yuting Liu , Mengchen Lu , Hongli Shao , Jing Zhao , Xiaoli Xu , Xiaoke Guo , Lei Wang
- Applicant: CHINA PHARMACEUTICAL UNIVERSITY
- Applicant Address: CN Jiangsu
- Assignee: CHINA PHARMACEUTICAL UNIVERSITY
- Current Assignee: CHINA PHARMACEUTICAL UNIVERSITY
- Current Assignee Address: CN Jiangsu
- Agency: JCIP GLOBAL INC.
- Priority: CN 1910673326.3 2019.07.24
- International Application: PCT/CN2020/084460 2020.04.13
- International Announcement: WO2021/012721A 2021.01.28
- Date entered country: 2022-01-12
- Main IPC: A61K31/63
- IPC: A61K31/63 ; C07C311/29 ; C07D307/79 ; A61K31/343

Abstract:
Disclosed in the present invention are a naphthalenesulfonamide compound, a preparation method, and an application. The naphthalenesulfonamide compound provided by the present invention can interfere with Keap1-Nrf2 binding and activate Nrf2 to relieve inflammatory damage and improve an inflammatory microenvironment, has a potential anti-inflammatory activity, and can be used for preparing an anti-inflammatory drug for inflammatory damage of various inflammation-related diseases, including chronic obstructive pulmonary disease (COPD), Alzheimer's disease, Parkinson's disease, atherosclerosis, chronic kidney disease (CKD), diabetes, intestinal Inflammations, rheumatoid arthritis, etc.
Public/Granted literature
- US20220251035A1 NAPHTHALENESULFONAMIDE COMPOUND, PREPARATION METHOD, AND APPLICATION Public/Granted day:2022-08-11
Information query